Filing Details
- Accession Number:
- 0001209191-24-000374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-03 16:25:11
- Reporting Period:
- 2023-12-29
- Accepted Time:
- 2024-01-03 16:25:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1810182 | Alx Oncology Holdings Inc | ALXO | Pharmaceutical Preparations (2834) | 850642577 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1817127 | Sophia Randolph | C/O Alx Oncology Holdings Inc. 323 Allerton Avenue South San Francisco CA 94080 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-12-29 | 3,128 | $15.04 | 312,349 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
Billionaire Hedge Funds
